Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Evelo Biosciences, Inc. | eveloq32018exhibit321.htm |
| EX-31.2 - EXHIBIT 31.2 - Evelo Biosciences, Inc. | eveloq32018exhibit312.htm |
| EX-31.1 - EXHIBIT 31.1 - Evelo Biosciences, Inc. | eveloq32018exhibit311.htm |
| 10-Q - 10-Q - Evelo Biosciences, Inc. | eveloq310-q2018.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Jonathan Poole, Chief Financial Officer of Evelo Biosciences, Inc. (the “Company”), hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
(1) | The Quarterly Report on Form 10-Q of the Company for the period ended September 30, 2018 (the “Report”) fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
Date: November 2, 2018 | By: | /s/ Jonathan Poole | |||
Jonathan Poole | |||||
Chief Financial Officer | |||||
(Principal Financial and Accounting Officer) | |||||